EUVIMEDEUVIMED entdecken
Crossref

Elevated transferrin receptor 1 promoting B-cell autoimmunity in systemic lupus erythematosus

Tohtihan Alim, Bin Yang, Yaqi Zhang, Wei Huang, Hanying Deng, Jingjing Zhang, Qingfeng Zhang, Zirui Yang, Wenqian Yi, Betty P Tsao, Xiaojun Tang, Xuebing Feng und 1 weitere

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Tohtihan Alim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Receptors, Transferrin, B-Lymphocytes, Antigens, CD. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transferrin receptor 1 (TFR1), a major iron receptor for immune cells, could impair T cell metabolism and function in systemic lupus erythematosus (SLE), leading us to investigate the effects of TFR1 and possible mechanisms on lupus B cells. METHODS: B cells from lupus mouse models and systemic lupus erythematosus (SLE) patients were evaluated using flow cytometry (FCM) for levels of TFR1, intracellular iron deposition, reactive oxygen species (ROS), lipid peroxidation, and B-cell subsets. Transcript levels of TFR1 were assessed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and upstream regulatory molecules were identified by in vitro gene silencing. RESULTS: An agonist of toll-like receptor 7 (TLR7), R848 treatment significantly increased TFR1 expression in B cells from C57BL/6 (B6) mice but not those from MRL/lpr mice. In in vitro cultures of mouse splenocytes, TLR7 dose-dependently promoted TFR1 expression, and its effect was probably mediated by P53. Anti-TFR1 antibody effectively inhibited intracellular iron deposition in lupus B cells, reduced ROS and lipid peroxidation, and prevented the production of plasmablasts and autoantibodies. Among different B cell subsets, TFR1 was predominantly expressed in double negative (DN) B cells, with a more pronounced effect on DN2 B cells, which could be normalized by ROS inhibitors. Similarly, in human studies, TFR1 was highly expressed in B cells of SLE patients and closely correlated with TLR7 expression and disease activity scores, as well as iron deposition and ROS production. A significant reduction in ROS production was observed after blocking TFR1. CONCLUSIONS: TLR7-regulated TFR1 may drive B-cell autoimmunity by promoting ROS production, thus contributing to SLE pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicReceptors, TransferrinB-LymphocytesAntigens, CDAnimalsHumansToll-Like Receptor 7Mice, Inbred C57BLFemaleReactive Oxygen SpeciesMiceAutoimmunityMice, Inbred MRL lprIronAdultMaleCells, CulturedDisease Models, AnimalMiddle AgedMembrane Glycoproteins

Stichwörter der Autor:innen

B lymphocytesSystemic lupus erythematosusToll-like receptor 7Transferrin receptor 1

Substanzen

Receptors, TransferrinToll-Like Receptor 7Reactive Oxygen SpeciesIronTLR7 protein, humanCD71 antigenAntigens, CDTlr7 protein, mouseMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital,…
  • Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
  • Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address: xjtang09@163.com.

Förderung

  • Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital

Zitieren

APA

Alim, T., Yang, B., Zhang, Y., Huang, W., Deng, H., Zhang, J., Zhang, Q., Yang, Z., Yi, W., Tsao, B. P., Tang, X., Feng, X., & Sun, L. (2025). Elevated transferrin receptor 1 promoting B-cell autoimmunity in systemic lupus erythematosus. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114804

Vancouver

Alim T, Yang B, Zhang Y, Huang W, Deng H, Zhang J, et al. Elevated transferrin receptor 1 promoting B-cell autoimmunity in systemic lupus erythematosus. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114804

BibTeX
@article{Alim2025,
  author = {Alim, Tohtihan and Yang, Bin and Zhang, Yaqi and Huang, Wei and Deng, Hanying and Zhang, Jingjing and Zhang, Qingfeng and Yang, Zirui and Yi, Wenqian and Tsao, Betty P and Tang, Xiaojun and Feng, Xuebing and Sun, Lingyun},
  title = {Elevated transferrin receptor 1 promoting B-cell autoimmunity in systemic lupus erythematosus},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114804}
}
Kostenlos starten →